. "Appendix III: Purchaser Payer Background Information." The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press, 2002.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
TABLE 1 Ranking of Top 16 Principal Diagnosis Disease Cohorts*
Condition
Ranking of Total allowed dollars
Ranking of Total allowed dollars per patient per year
Ranking of Admits per patient per year
Ranking of ER visits per patient per year
Cancer
1
2
10
16
Ischemic Heart Disease
24
4
1
2
Other Heart Disease
35
5
1
1
Injury
4
13
15
1
Congestive Heart Failure
5
1
1
8
Diabetes
6
10
9
6
Congestive Obstructive Pulmonary Disease
7
9
7
7
Complications of Medical and Surgical Care
8
3
3
5
Arthropathies
9
14
13
14
Dorsopathies
10
12
14
9
Psychiatric conditions
11
11
12
4
Disease of Liver, Pancreas
12
8
8
10
Disorder of Female Genital Organs
13
16
16
15
Cerebrovascular Disease
14
6
6
13
Complication of Pregnancy
15
7
2
3
Asthma
16
15
11
2
*Data from a large Commercial and Medicare+Choice HMO population in 2000 in the southeastern United States. Members may appear in more than one category.
